Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Maximizing credit card point value can lead to incredible benefits. Discover effective strategies to boost your rewards potential.
25,565 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A new set of futures is coming to the CME Group, tying Tesla and SpaceX to a cash-settled futures contract. This arti...
SpaceX's $7.7 billion AI infrastructure push in Q1 2026 marks a dramatic shift from traditional rocket business to da...
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
The S&P 500’s top ten names now control a record share of the index, a dynamic that could ripple into Bitcoin and the...
Investing in AI can feel like riding a hype wave. This article digs into what makes a stock a true money-maker, unvei...
River Road Asset Management just added a notable new position in AptarGroup, acquiring 917,670 shares valued at about...
Berkshire Hathaway has resumed stock buybacks, purchasing $15 million of its own shares. CEO Greg Abel personally bou...
When Micron announced a Taiwanese site acquisition, micron stock popped today and sparked a broader discussion about ...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Patient investors who focus on durable competitive advantages can unlock meaningful returns. This article explains a ...
CoreCivic has faced a share-price headwind even as revenue climbs. A notable $5 million stake by Hahn Capital signals...